On July 1, 2014, the Irish Medicines Board (IMB) will change its name to the Health Products Regulatory Authority (HPRA).

Established in 1996, the IMB name is well known. However, over the last 18 years the organization has expanded its regulatory activities to include other health products and health related functions. In addition to human and veterinary medicines, it now has a role in regulating a range of areas including: 

  • Medical devices
  • Controlled drugs
  • Clinical trials
  • Blood products and components
  • Tissues and cells
  • Cosmetic products
  • The protection of animals used for scientific purposes
  • Organs intended for transplantation

The new name more clearly reflects the wider scope of its work, functions and responsibilities across the health products sector. 

Note: IMB’s email addresses will change from @imb.ie to @hpra.ie on July 1.